International Union of Pharmacology. XXVIII. Proteinase-activated receptors

Pharmacological Reviews

Volumn 54, Issue 2, 2002, Pages 203-217

  Hollenberg, Morley D ^a   Compton, Steven J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; TRYPSIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARCINOGENESIS; ENZYME ACTIVATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TISSUE INJURY; TISSUE REPAIR;

HUMANS; INTERNATIONAL AGENCIES; OLIGOPEPTIDES; RECEPTORS, THROMBIN; STRUCTURE-ACTIVITY RELATIONSHIP; TERMINOLOGY;

EID: 0036262319     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.54.2.203     Document Type: Review

References (110)

1. A study of the adrenotropic receptors
2. Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor
3. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl) phenyl]methyl]-7H-pyrrolo[3, 2-flquinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
4. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle
5. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation
6. Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2
7. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following angioplasty in rats
8. Design, synthesis and biological characterization of a peptide-mimetic antagonist for a tethered ligand receptor
9. Identification of a novel thrombin receptor sequence required for activation-dependent responses
10. Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
11. Hormone-like activity of human thrombin
12. Development of potent thrombin receptor antagonist peptides
13. Ligand cross-reactivity within the protease-activated receptor family
14. Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide
15. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2
16. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2
17. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2
18. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
19. Thrombin receptor-activating peptides (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic and computational studies
20. Thrombin receptor antagonists as novel therapeutic targets
21. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode
22. Inflammation-coagulation network: Are serine protease receptors the knot?
23. Protease-activated receptors: Sentries for inflammation?
24. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists
25. Glycosylation and the activation of proteinase-activated receptor 2 (PAR2) by human mast cell tryptase
26. Role of the thrombin receptor in development and evidence for a second receptor
27. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2
28. Thrombin signalling and protease-activated receptors
29. Characterization of proteaseactivated receptor-2 immunoreactivity in normal human tissues
30. Beta-arrestin-dependent endocytosis of proteinase -activated receptor 2 is required for intracellular targeting of activated ERK1/2
31. Agonists of proteinase-activated receptor I induce plasma extravasation by a neurogenic mechanism
32. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteinases
33. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. Beta-Arrestin-dependent endocytosis of a proteinase receptor
34. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin
35. Thrombin receptor overexpression in malignant and physiological invasion processes
36. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function
37. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface
38. Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis
39. A role for thrombin receptor signaling in endothelial cells during embryonic development
40. Protease -activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: Evidence for a novel mechanism preventing or terminating signaling by PARI's tethered ligand
41. Shutoff and agonist-triggered internalization of protease-activated receptor I can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail
42. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor
43. Role of thrombin receptor in breast cancer invasiveness
44. Protease-mediated signalling: New paradigms for cell regulation and drug development
45. Role of the amino and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: Evidence for receptor subtypes
46. Proteinase-activated receptor 4 (PAR4): Activation and inhibition of rat platelet aggregation by PAR4-derived peptides
47. Proteinase-activated receptor-2 in rat aorta: Structural requirements for agonist activity of receptor-activating peptides
48. Proteinase-activated receptor 4 (PAR4): Action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2
49. Action of thrombin receptor polypeptide in gastric smooth muscle: Identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity
50. Internalization and recycling of activated thrombin receptors
51. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase
52. Protease-activated receptor 3 is a second thrombin receptor in humans
53. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases
54. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
55. A dual thrombin receptor system for platelet activation
56. Signaling from protease activated receptor-1 inhibits migration and invasion of breast cancer cells
57. Evaluation of proteinase receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR2 by PARl-targeted ligands
58. Plasminplatelet interaction involves cleavage of functional thrombin receptor
59. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets
60. Luminal trypsin may regulate enterocytes through proteinase-activated receptor
61. Expression of trypsin in vascular endothelial cells
62. The role of receptor kinases and arrestins in G protein-coupled receptor regulation
63. Plasmin desensitization of the PAR1 thrombin receptor: Kinetics, sites of truncation and implications for thrombolytic therapy
64. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species
65. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function
66. Proteolysis of the exodomain of recombinant protease-activated receptors: Prediction of receptor activation or inactivation by mass spectrometry
67. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist
68. Proteinase-activated receptors
69. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways
70. Protease-activated receptor-2 (PAR2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes
71. Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1
72. Interactions of mast cell tryptase with thrombin receptors and PAR-2
73. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G
74. PAR3 is a cofactor for PAR4 activation by thrombin
75. Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site
76. Tethered ligand derived pentapeptide agonists of thrombin receptor: A study of side chain requirements for human platelet activation and GTPase stimulation
77. Molecular cloning of a potential proteinase activated receptor
78. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo
79. Protease activated receptors: Theme and variations
80. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1
81. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets
82. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor
83. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets
84. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization
85. Protease-activated receptor antagonists
86. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: Evidence for receptor heterogeneity
87. Cathepsin G activates protease-activated receptor-4 in human platelets
88. Role of thrombin signalling in platelets in haemostasis and thrombosis
89. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function
90. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist
91. Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization
92. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin
93. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib
94. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
95. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes
96. Interaction of mite allergens der p3 and der p9 with protease-activated receptor-2 expressed by lung epithelial cells
97. PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit
98. Cellular localization of membrane-type serine protease I and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates
99. The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling
100. Structure-function relationships in the activation ofplatelet thrombin receptors by receptor-derived peptides
101. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
102. Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport
103. Protease-activated receptors in inflammation, neuronal signaling and pain
104. The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors
105. Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor
106. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
107. Domains specifying thrombin-receptor interaction
108. Cloning and characterization of human protease-activated receptor 4
109. Discovery and optimization of a novel series of thrombin receptor (PAR-1) antagonists: Potent, selective peptide mimetics based on indole and indazole templates